This sets out proposed new care models for glaucoma patients in order to better utilise primary care capacity, while still maintaining patient safety.
Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.
In each issue, Acuity poses a topical question on a tricky scenario to a panel of members.
Clinical files: What impact should a patient's home genetics test have on my clinical decision-making?
Read the guidance on examining patients at risk from glaucoma
This member briefing covers the guideline on Glaucoma: diagnosis and management
Find out more about getting a College-accredited higher qualification in glaucoma.
More information for patients on glaucoma, including a directory to find their nearest optometrist member.
As the world observes World Glaucoma Week (12-18 March), the College wants to highlight the resources we offer to help optometrists provide the best possible care to their patients with glaucoma.
We have submitted our response to the All Wales Common Ailments Service formulary consultation
Supporting information for primary care optometry on EyeCee One preloaded and EyeCee One Crystal preloaded intraocular lenses.
The College is asking for feedback from members on changes to its patient leaflets.
Optometry Tomorrow Bitesize conference will be taking place virtually from Sunday 23 to Friday 28 April 2023.
A glance at what’s happening in the world of technology - Autumn 2022.
Ageing and eye health series
Kathy Oxtoby introduces the first article in a series on an ageing population and the implications for eye health and the optometry profession in the UK.
Clinical Files: Is it sufficient to undertake non-invasive measures of anterior chamber depth to determine whether my patient is a primary angle closure suspect?
The clinical figures that count.
The glaucoma expert on his research and educating the next generation.
Clinical Files: Do I have to complete a new sight test, even though they are within their recall period?